glp 1 muscle Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP‐1 receptor agonists and muscle

Miras AD, Prez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, et al

The LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial was a pivotal milestone as it showed the cardiovascular benefits of liraglutide in patients with T2D and high cardiovascular risk

The ongoing Yoga-EndOmics trial is designed to examine how yoga-based cardiac rehabilitation influences endothelial function, arterial stiffness, and redox-relevant genomic pathways in heart failure, reflecting growing recognition that integrative movement modalities may support mitochondrial and vascular health through coordinated metabolic and neurohumoral mechanisms (27)

doi: 10.2147/PPA.S29716 6 AlvesN

Because pigmentation reflects downstream cellular changes rather than an immediate on/off response, observed effects are typically gradual and depend on individual biology, baseline skin type, UV exposure, and melanocyte activity